Pharma2Care SA
Pharma2Care reported total assets of €1.79m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Oct 2026).
The score of Pharma2Care shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +32 % Total assets -31 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma2Care's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Oct 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Pharma2Care's financial analysis
- Solvency88.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma2Care
Pharma2Care's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0427.391.896
- VAT number
- BE0427391896
- Peppol
- Registered · 0208:0427391896 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 May 1985
- Registered office
- 8377 Zuienkerke
- Latest accounts
- 2025 · filed on 23 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma2Care (SA) has been based in Zuienkerke since 1985, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 541,117 € and equity of €1.58m; its revenue is not published. Its solvency stands at 88.4%, above the median of its sector (44.2%).
Companies similar to Pharma2Care
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- APO2370 Retail sale of pharmaceutical products Arendonk · balance sheet €3.86m
- Boskant Retail sale of pharmaceutical products Merchtem · balance sheet 729,117 €
- Apotheek Dessein Retail sale of pharmaceutical products Beernem · balance sheet €9.75m
- Tornaphar Retail sale of pharmaceutical products Tournai · balance sheet €3.74m
- EDEHealth Services Business and other management consultancy activities Beyne-Heusay · balance sheet 23,732 €
- ELA Services Retail sale of pharmaceutical products Uccle · balance sheet 920,384 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
Frequently asked questions about Pharma2Care
What is the revenue of Pharma2Care?
Pharma2Care files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma2Care?
In Belgium, the VAT number is the company number prefixed with BE: BE0427391896 for Pharma2Care, if the company is VAT-registered. Its company number (CBE) is 0427.391.896.
Where is the registered office of Pharma2Care?
According to the CBE register, the registered office of Pharma2Care is in 8377 Zuienkerke.
What is the equity of Pharma2Care?
At the close of the 2025 financial year, the equity of Pharma2Care amounts to 1,581,457 €, a solvency of 88.4% of total assets.
Who manages Pharma2Care?
The register lists 2 active mandates at Pharma2Care. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma2Care
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →